A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties
Crossref DOI link: https://doi.org/10.1186/s12885-015-1868-7
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kastrati, Irida
Litosh, Vladislav A.
Zhao, Shuangping
Alvarez, Manuel
Thatcher, Gregory R. J.
Frasor, Jonna
License valid from 2015-11-04